Navigation Links
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
Date:8/4/2011

candidates for future development; unexpected new data, safety and/or technical issues; our clinical trials may not start when planned, be completed in a timely manner and/or confirm previous results; our clinical studies may not be predictive or achieve intended results; our product candidates, including any product candidates we decide to develop with Takeda for the treatment of obesity, may not receive regulatory approval; any financial guidance we provide may differ from our actual future financial results; and inherent scientific, regulatory and other risks associated in the drug development and commercialization process. These and additional risks and uncertainties are described more fully in Amylin's most recently filed SEC documents, including its Annual Report on Form 10-K. Amylin undertakes no duty to update these forward-looking statements.

Forward-Looking Statements Related to Takeda

This press release contains forward-looking statements about Takeda. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-loo
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Second Quarter Results
2. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
3. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
4. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
5. Lilly Comments on Court Ruling in Amylin Litigation
6. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
7. Lilly Provides Its Perspective in Response to Amylin Lawsuit
8. Lilly Provides Statement in Response to Amylin Lawsuit
9. Amylin Pharmaceuticals Files Suit Against Eli Lilly
10. JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
11. Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the ... closing of $12.5 million in new financing led by ... The funding will further GlassesUSA,s aggressive business growth and accelerate ... market of online eyewear, both B2C and B2B. ... , COO Eldad Rothman , and CTO Roy ...
(Date:3/30/2015)... Mass. , March 30, 2015 Alere ... rapid diagnostics, issued the following statement today in support ... to Combat Antibiotic-Resistant Bacteria. "As the ... commend President Barack Obama for establishing a ... to address the serious threat of antibiotic resistance. We ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/h699d6/global_healthcare ) has ... Computing Market 2015-2019" report to their offering. ... market to grow at a CAGR of 21.95 percent ... IT in healthcare has led to a rise in ... industry. Though there are significant challenges such as high ...
Breaking Medicine Technology:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2Global Healthcare Cloud Computing Market 2015-2019 with Agfa, CareCloud, Carestream Health, Cisco, ClearData Networks, Dell, GE & Merge Healthcare Dominating 2
... 2011 Reportlinker.com announces that a new market ... Hong Kong SMBG Devices and Strips ... This Market Engineering research service has ... glucose monitoring device sales and consumption of test ...
... MADISON, N.J., May 17, 2011 Quest Diagnostics Incorporated ... of diagnostic testing, information and services, announced today the ... CRA).  The acquisition was completed by means of a ... owned subsidiary of Quest Diagnostics was merged with and ...
Cached Medicine Technology:Reportlinker Adds Hong Kong SMBG Devices and Strips Market 2Reportlinker Adds Hong Kong SMBG Devices and Strips Market 3Reportlinker Adds Hong Kong SMBG Devices and Strips Market 4Reportlinker Adds Hong Kong SMBG Devices and Strips Market 5Reportlinker Adds Hong Kong SMBG Devices and Strips Market 6Quest Diagnostics Successfully Completes Acquisition of Celera 2
(Date:3/30/2015)... 2015 Innovaacom, a leading provider of ... announced it is expanding its services into Asia in ... of the world comes at a time when Asia’s ... for better healthcare. A rapidly growing aging population and ... advances in medicine in Asia. “We are excited to ...
(Date:3/30/2015)... March 30, 2015 On March 29, 2015 ... Day. In honor of all small business owners, for their ... spotlighting them. , According to Zane Benefits' website, small ... economy, creating 75% of all jobs and employing over 60 ... for 54% of all U.S. sales. The small business sector ...
(Date:3/30/2015)... On March 19th, 2015, in the ... the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction Together” ... and bishops as well as other civic leaders and ... the luncheon, including retired Detroit Lions wide receiver Herman ... two survivors of their own personal battles with addiction, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Valerie Harper, ... 1970s sitcoms “Rhoda” and “The Mary Tyler Moore Show,” ... ceremony honoring oncology nurses, CURETM magazine announced today. Harper, ... of the Oncology Nursing Society’s 40th Annual Congress on ... the important role oncology nurses play in the lives ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 V/NO ... that includes a convenient flute for opening/closing and for reuse. ... wine on the go. Health-conscious New Yorkers, professionals, and basically ... is sophisticated yet delicious to kick back socially or pair ... arise. , “ V/NO is dealcoholized wine and that ...
Breaking Medicine News(10 mins):Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2
... Oct. 18 The following statement,is attributable to: ... American Medical Association (AMA) welcomes today,s decision by,New ... a consumer warning,about the potentially deceptive programs used ... AMA is committed to the goal of empowering ...
... Chorus: ,It Takes A Village, October 27 and 28, ... Sing, a,not-for-profit organization founded by Chicago resident Melinda Pollack,was ... a,musical outlet for singers whose lives have been touched ... that celebrates hope and survival,provides its singers a venue ...
... Oct. 18 West Pharmaceutical,Services, Inc. (NYSE: ... announcement that it has decided to discontinue marketing ... to the,Company,s customer, Nektar Therapeutics, Inc. The Company,s ... the Exubera inhalation device for Nektar. "We ...
... of,Dental Plans (NADP) calls on Congress and the Administration ... (CHIP).,Specifically, NADP urges prompt action to enact the dental ... In letters to congressional health policy leaders, NADP ... services should be a mandatory CHIP benefit. ...
... SANTA CLARA, Calif., Oct. 18 Align,Technology, Inc. ... a proprietary,method of straightening teeth without wires or ... by the Academy of General,Dentistry,s (AGD) Program Approval ... evaluation of the educational processes used in designing,planning ...
... Surgical Care Affiliates,(SCA) has named Ali Reza as its ... responsible for a variety of ongoing initiatives and,projects as ... are pleased to bring someone with Ali,s experience to ... "His previous work,in the areas of operational turnaround and ...
Cached Medicine News:Health News:Breast Cancer Survivors and Their Supporters 'Sing to Live' 2Health News:West Pharmaceutical Services Issues Statement on Exubera 2Health News:West Pharmaceutical Services Issues Statement on Exubera 3Health News:West Pharmaceutical Services Issues Statement on Exubera 4Health News:NADP Calls on Congress and the White House to Work Together to Cover Children's Dental Health 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 3